| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.09 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.099 | 0.09 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.09 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.1 |